Science
Addressing the large unmet medical need to develop more effective and less burdensome therapies for patients and their caregivers.
Pipeline
Developing danegaptide, an orally administered, small molecule drug with a novel mode of action.
Developing orally administered P2X7 receptor antagonists with anti-inflammatory and neuroprotective properties.